nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—CYP2C19—coronary artery disease	0.219	1	CbGaD
Etravirine—ABCB1—Ticagrelor—coronary artery disease	0.023	0.043	CbGbCtD
Etravirine—CYP2C9—Fenofibrate—coronary artery disease	0.0211	0.0395	CbGbCtD
Etravirine—CYP2C19—Gemfibrozil—coronary artery disease	0.0203	0.038	CbGbCtD
Etravirine—CYP2C19—Clopidogrel—coronary artery disease	0.0176	0.0329	CbGbCtD
Etravirine—CYP2C9—Gemfibrozil—coronary artery disease	0.0169	0.0316	CbGbCtD
Etravirine—CYP2C19—Telmisartan—coronary artery disease	0.0154	0.0288	CbGbCtD
Etravirine—CYP2C9—Clopidogrel—coronary artery disease	0.0146	0.0274	CbGbCtD
Etravirine—ABCB1—Clopidogrel—coronary artery disease	0.0142	0.0266	CbGbCtD
Etravirine—ABCB1—Perindopril—coronary artery disease	0.0142	0.0266	CbGbCtD
Etravirine—CYP3A4—Ticagrelor—coronary artery disease	0.0138	0.0258	CbGbCtD
Etravirine—CYP2C9—Pitavastatin—coronary artery disease	0.0128	0.0239	CbGbCtD
Etravirine—CYP2C9—Valsartan—coronary artery disease	0.0124	0.0233	CbGbCtD
Etravirine—ABCB1—Pitavastatin—coronary artery disease	0.0124	0.0232	CbGbCtD
Etravirine—ABCB1—Telmisartan—coronary artery disease	0.0124	0.0232	CbGbCtD
Etravirine—CYP2C19—Timolol—coronary artery disease	0.0124	0.0232	CbGbCtD
Etravirine—CYP3A4—Fenofibrate—coronary artery disease	0.0123	0.023	CbGbCtD
Etravirine—ABCB1—Lisinopril—coronary artery disease	0.0118	0.022	CbGbCtD
Etravirine—ABCB1—Enalapril—coronary artery disease	0.0118	0.022	CbGbCtD
Etravirine—CYP2C19—Rosuvastatin—coronary artery disease	0.0113	0.0212	CbGbCtD
Etravirine—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.011	0.0207	CbGbCtD
Etravirine—CYP2C19—Simvastatin—coronary artery disease	0.0105	0.0197	CbGbCtD
Etravirine—CYP2C19—Lovastatin—coronary artery disease	0.0103	0.0193	CbGbCtD
Etravirine—ABCB1—Timolol—coronary artery disease	0.00999	0.0187	CbGbCtD
Etravirine—CYP3A4—Gemfibrozil—coronary artery disease	0.0098	0.0184	CbGbCtD
Etravirine—CYP2C9—Rosuvastatin—coronary artery disease	0.00942	0.0176	CbGbCtD
Etravirine—CYP2C19—Atorvastatin—coronary artery disease	0.00939	0.0176	CbGbCtD
Etravirine—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00918	0.0172	CbGbCtD
Etravirine—ABCB1—Ezetimibe—coronary artery disease	0.00914	0.0171	CbGbCtD
Etravirine—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00891	0.0167	CbGbCtD
Etravirine—ABCB1—Captopril—coronary artery disease	0.0088	0.0165	CbGbCtD
Etravirine—CYP2C9—Simvastatin—coronary artery disease	0.00876	0.0164	CbGbCtD
Etravirine—CYP2C19—Losartan—coronary artery disease	0.00859	0.0161	CbGbCtD
Etravirine—CYP2C9—Lovastatin—coronary artery disease	0.00857	0.016	CbGbCtD
Etravirine—CYP2C9—Pravastatin—coronary artery disease	0.00857	0.016	CbGbCtD
Etravirine—CYP3A4—Clopidogrel—coronary artery disease	0.0085	0.0159	CbGbCtD
Etravirine—ABCB1—Simvastatin—coronary artery disease	0.0085	0.0159	CbGbCtD
Etravirine—ABCB1—Pravastatin—coronary artery disease	0.00832	0.0156	CbGbCtD
Etravirine—ABCB1—Lovastatin—coronary artery disease	0.00832	0.0156	CbGbCtD
Etravirine—CYP3A4—Eplerenone—coronary artery disease	0.0079	0.0148	CbGbCtD
Etravirine—CYP2C9—Atorvastatin—coronary artery disease	0.0078	0.0146	CbGbCtD
Etravirine—ABCB1—Atorvastatin—coronary artery disease	0.00757	0.0142	CbGbCtD
Etravirine—CYP2C9—Losartan—coronary artery disease	0.00714	0.0134	CbGbCtD
Etravirine—CYP3A4—Enalapril—coronary artery disease	0.00704	0.0132	CbGbCtD
Etravirine—ABCB1—Losartan—coronary artery disease	0.00693	0.013	CbGbCtD
Etravirine—CYP3A4—Rosuvastatin—coronary artery disease	0.00548	0.0103	CbGbCtD
Etravirine—CYP3A4—Ezetimibe—coronary artery disease	0.00548	0.0103	CbGbCtD
Etravirine—CYP3A4—Simvastatin—coronary artery disease	0.00509	0.00954	CbGbCtD
Etravirine—CYP3A4—Lovastatin—coronary artery disease	0.00498	0.00933	CbGbCtD
Etravirine—CYP3A4—Pravastatin—coronary artery disease	0.00498	0.00933	CbGbCtD
Etravirine—CYP3A4—Atorvastatin—coronary artery disease	0.00454	0.0085	CbGbCtD
Etravirine—CYP3A4—Losartan—coronary artery disease	0.00415	0.00777	CbGbCtD
Etravirine—CYP2C9—cardial valve—coronary artery disease	0.00342	0.543	CbGeAlD
Etravirine—ABCB4—heart—coronary artery disease	0.00103	0.164	CbGeAlD
Etravirine—Rilpivirine—CYP2C19—coronary artery disease	0.000913	1	CrCbGaD
Etravirine—ABCB4—blood—coronary artery disease	0.00077	0.122	CbGeAlD
Etravirine—CYP2C9—heart—coronary artery disease	0.000189	0.03	CbGeAlD
Etravirine—CYP2C19—blood—coronary artery disease	0.000182	0.0289	CbGeAlD
Etravirine—CYP2C9—cardiovascular system—coronary artery disease	0.000178	0.0283	CbGeAlD
Etravirine—CYP2C9—blood—coronary artery disease	0.000141	0.0224	CbGeAlD
Etravirine—CYP3A4—blood—coronary artery disease	0.000107	0.0171	CbGeAlD
Etravirine—ABCB1—heart—coronary artery disease	0.000102	0.0162	CbGeAlD
Etravirine—ABCB1—cardiovascular system—coronary artery disease	9.62e-05	0.0153	CbGeAlD
Etravirine—ABCB1—blood—coronary artery disease	7.61e-05	0.0121	CbGeAlD
Etravirine—Gastrointestinal disorder—Furosemide—coronary artery disease	6.66e-05	0.000369	CcSEcCtD
Etravirine—Fatigue—Furosemide—coronary artery disease	6.65e-05	0.000368	CcSEcCtD
Etravirine—Tremor—Lisinopril—coronary artery disease	6.65e-05	0.000368	CcSEcCtD
Etravirine—Abdominal pain—Telmisartan—coronary artery disease	6.65e-05	0.000368	CcSEcCtD
Etravirine—Body temperature increased—Telmisartan—coronary artery disease	6.65e-05	0.000368	CcSEcCtD
Etravirine—Anxiety—Ramipril—coronary artery disease	6.64e-05	0.000368	CcSEcCtD
Etravirine—Vomiting—Lovastatin—coronary artery disease	6.63e-05	0.000367	CcSEcCtD
Etravirine—Somnolence—Losartan—coronary artery disease	6.62e-05	0.000367	CcSEcCtD
Etravirine—Dizziness—Eplerenone—coronary artery disease	6.61e-05	0.000366	CcSEcCtD
Etravirine—Rash—Clopidogrel—coronary artery disease	6.61e-05	0.000366	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	6.61e-05	0.000366	CcSEcCtD
Etravirine—Dermatitis—Clopidogrel—coronary artery disease	6.61e-05	0.000366	CcSEcCtD
Etravirine—Asthenia—Valsartan—coronary artery disease	6.6e-05	0.000366	CcSEcCtD
Etravirine—Hypertension—Timolol—coronary artery disease	6.6e-05	0.000366	CcSEcCtD
Etravirine—Pain—Furosemide—coronary artery disease	6.6e-05	0.000365	CcSEcCtD
Etravirine—Constipation—Furosemide—coronary artery disease	6.6e-05	0.000365	CcSEcCtD
Etravirine—Hypersensitivity—Niacin—coronary artery disease	6.59e-05	0.000365	CcSEcCtD
Etravirine—Ill-defined disorder—Lisinopril—coronary artery disease	6.58e-05	0.000365	CcSEcCtD
Etravirine—Discomfort—Ramipril—coronary artery disease	6.58e-05	0.000364	CcSEcCtD
Etravirine—Asthenia—Olmesartan—coronary artery disease	6.57e-05	0.000364	CcSEcCtD
Etravirine—Headache—Clopidogrel—coronary artery disease	6.57e-05	0.000364	CcSEcCtD
Etravirine—Rash—Lovastatin—coronary artery disease	6.57e-05	0.000364	CcSEcCtD
Etravirine—Dermatitis—Lovastatin—coronary artery disease	6.56e-05	0.000364	CcSEcCtD
Etravirine—Anaemia—Lisinopril—coronary artery disease	6.56e-05	0.000363	CcSEcCtD
Etravirine—Feeling abnormal—Perindopril—coronary artery disease	6.54e-05	0.000362	CcSEcCtD
Etravirine—Headache—Lovastatin—coronary artery disease	6.53e-05	0.000362	CcSEcCtD
Etravirine—Dry mouth—Ramipril—coronary artery disease	6.51e-05	0.000361	CcSEcCtD
Etravirine—Vomiting—Ezetimibe—coronary artery disease	6.5e-05	0.00036	CcSEcCtD
Etravirine—Hypersensitivity—Pravastatin—coronary artery disease	6.49e-05	0.00036	CcSEcCtD
Etravirine—Gastrointestinal pain—Perindopril—coronary artery disease	6.49e-05	0.00036	CcSEcCtD
Etravirine—Anxiety—Timolol—coronary artery disease	6.49e-05	0.000359	CcSEcCtD
Etravirine—Angioedema—Lisinopril—coronary artery disease	6.48e-05	0.000359	CcSEcCtD
Etravirine—Decreased appetite—Losartan—coronary artery disease	6.47e-05	0.000358	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	6.46e-05	0.000358	CcSEcCtD
Etravirine—Body temperature increased—Captopril—coronary artery disease	6.46e-05	0.000358	CcSEcCtD
Etravirine—Abdominal pain—Captopril—coronary artery disease	6.46e-05	0.000358	CcSEcCtD
Etravirine—Dizziness—Simvastatin—coronary artery disease	6.45e-05	0.000357	CcSEcCtD
Etravirine—Rash—Ezetimibe—coronary artery disease	6.44e-05	0.000357	CcSEcCtD
Etravirine—Dermatitis—Ezetimibe—coronary artery disease	6.44e-05	0.000357	CcSEcCtD
Etravirine—Confusional state—Ramipril—coronary artery disease	6.44e-05	0.000357	CcSEcCtD
Etravirine—Discomfort—Timolol—coronary artery disease	6.43e-05	0.000356	CcSEcCtD
Etravirine—Asthenia—Niacin—coronary artery disease	6.42e-05	0.000356	CcSEcCtD
Etravirine—Fatigue—Losartan—coronary artery disease	6.42e-05	0.000356	CcSEcCtD
Etravirine—Headache—Ezetimibe—coronary artery disease	6.4e-05	0.000355	CcSEcCtD
Etravirine—Malaise—Lisinopril—coronary artery disease	6.4e-05	0.000354	CcSEcCtD
Etravirine—Vertigo—Lisinopril—coronary artery disease	6.37e-05	0.000353	CcSEcCtD
Etravirine—Dry mouth—Timolol—coronary artery disease	6.37e-05	0.000353	CcSEcCtD
Etravirine—Constipation—Losartan—coronary artery disease	6.37e-05	0.000353	CcSEcCtD
Etravirine—Pain—Losartan—coronary artery disease	6.37e-05	0.000353	CcSEcCtD
Etravirine—Syncope—Lisinopril—coronary artery disease	6.36e-05	0.000352	CcSEcCtD
Etravirine—Vomiting—Eplerenone—coronary artery disease	6.36e-05	0.000352	CcSEcCtD
Etravirine—Feeling abnormal—Furosemide—coronary artery disease	6.36e-05	0.000352	CcSEcCtD
Etravirine—Nausea—Fenofibrate—coronary artery disease	6.34e-05	0.000351	CcSEcCtD
Etravirine—Asthenia—Pravastatin—coronary artery disease	6.32e-05	0.00035	CcSEcCtD
Etravirine—Gastrointestinal pain—Furosemide—coronary artery disease	6.31e-05	0.000349	CcSEcCtD
Etravirine—Rash—Eplerenone—coronary artery disease	6.31e-05	0.000349	CcSEcCtD
Etravirine—Hypersensitivity—Trandolapril—coronary artery disease	6.3e-05	0.000349	CcSEcCtD
Etravirine—Dermatitis—Eplerenone—coronary artery disease	6.3e-05	0.000349	CcSEcCtD
Etravirine—Diarrhoea—Valsartan—coronary artery disease	6.3e-05	0.000349	CcSEcCtD
Etravirine—Confusional state—Timolol—coronary artery disease	6.29e-05	0.000349	CcSEcCtD
Etravirine—Shock—Ramipril—coronary artery disease	6.28e-05	0.000348	CcSEcCtD
Etravirine—Hypersensitivity—Enalapril—coronary artery disease	6.28e-05	0.000348	CcSEcCtD
Etravirine—Abdominal pain—Perindopril—coronary artery disease	6.27e-05	0.000348	CcSEcCtD
Etravirine—Body temperature increased—Perindopril—coronary artery disease	6.27e-05	0.000348	CcSEcCtD
Etravirine—Diarrhoea—Olmesartan—coronary artery disease	6.27e-05	0.000347	CcSEcCtD
Etravirine—Headache—Eplerenone—coronary artery disease	6.27e-05	0.000347	CcSEcCtD
Etravirine—Nervous system disorder—Ramipril—coronary artery disease	6.26e-05	0.000347	CcSEcCtD
Etravirine—Thrombocytopenia—Ramipril—coronary artery disease	6.25e-05	0.000346	CcSEcCtD
Etravirine—Loss of consciousness—Lisinopril—coronary artery disease	6.23e-05	0.000345	CcSEcCtD
Etravirine—Nausea—Clopidogrel—coronary artery disease	6.23e-05	0.000345	CcSEcCtD
Etravirine—Skin disorder—Ramipril—coronary artery disease	6.2e-05	0.000343	CcSEcCtD
Etravirine—Infection—Timolol—coronary artery disease	6.2e-05	0.000343	CcSEcCtD
Etravirine—Vomiting—Simvastatin—coronary artery disease	6.2e-05	0.000343	CcSEcCtD
Etravirine—Hypersensitivity—Telmisartan—coronary artery disease	6.19e-05	0.000343	CcSEcCtD
Etravirine—Nausea—Lovastatin—coronary artery disease	6.19e-05	0.000343	CcSEcCtD
Etravirine—Hyperhidrosis—Ramipril—coronary artery disease	6.17e-05	0.000342	CcSEcCtD
Etravirine—Rash—Simvastatin—coronary artery disease	6.15e-05	0.00034	CcSEcCtD
Etravirine—Dermatitis—Simvastatin—coronary artery disease	6.14e-05	0.00034	CcSEcCtD
Etravirine—Asthenia—Trandolapril—coronary artery disease	6.14e-05	0.00034	CcSEcCtD
Etravirine—Shock—Timolol—coronary artery disease	6.14e-05	0.00034	CcSEcCtD
Etravirine—Feeling abnormal—Losartan—coronary artery disease	6.13e-05	0.00034	CcSEcCtD
Etravirine—Diarrhoea—Niacin—coronary artery disease	6.12e-05	0.000339	CcSEcCtD
Etravirine—Nervous system disorder—Timolol—coronary artery disease	6.12e-05	0.000339	CcSEcCtD
Etravirine—Asthenia—Enalapril—coronary artery disease	6.11e-05	0.000339	CcSEcCtD
Etravirine—Headache—Simvastatin—coronary artery disease	6.11e-05	0.000338	CcSEcCtD
Etravirine—Abdominal pain—Furosemide—coronary artery disease	6.1e-05	0.000338	CcSEcCtD
Etravirine—Body temperature increased—Furosemide—coronary artery disease	6.1e-05	0.000338	CcSEcCtD
Etravirine—Gastrointestinal pain—Losartan—coronary artery disease	6.09e-05	0.000337	CcSEcCtD
Etravirine—Dizziness—Valsartan—coronary artery disease	6.09e-05	0.000337	CcSEcCtD
Etravirine—Anorexia—Ramipril—coronary artery disease	6.08e-05	0.000337	CcSEcCtD
Etravirine—Nausea—Ezetimibe—coronary artery disease	6.07e-05	0.000336	CcSEcCtD
Etravirine—Skin disorder—Timolol—coronary artery disease	6.06e-05	0.000336	CcSEcCtD
Etravirine—Dizziness—Olmesartan—coronary artery disease	6.06e-05	0.000336	CcSEcCtD
Etravirine—Hyperhidrosis—Timolol—coronary artery disease	6.03e-05	0.000334	CcSEcCtD
Etravirine—Asthenia—Telmisartan—coronary artery disease	6.03e-05	0.000334	CcSEcCtD
Etravirine—Diarrhoea—Pravastatin—coronary artery disease	6.03e-05	0.000334	CcSEcCtD
Etravirine—Anxiety—Lisinopril—coronary artery disease	6.02e-05	0.000333	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	6e-05	0.000332	CcSEcCtD
Etravirine—Discomfort—Lisinopril—coronary artery disease	5.97e-05	0.000331	CcSEcCtD
Etravirine—Anorexia—Timolol—coronary artery disease	5.95e-05	0.000329	CcSEcCtD
Etravirine—Nausea—Eplerenone—coronary artery disease	5.94e-05	0.000329	CcSEcCtD
Etravirine—Dizziness—Niacin—coronary artery disease	5.92e-05	0.000328	CcSEcCtD
Etravirine—Dry mouth—Lisinopril—coronary artery disease	5.91e-05	0.000327	CcSEcCtD
Etravirine—Abdominal pain—Losartan—coronary artery disease	5.88e-05	0.000326	CcSEcCtD
Etravirine—Body temperature increased—Losartan—coronary artery disease	5.88e-05	0.000326	CcSEcCtD
Etravirine—Asthenia—Captopril—coronary artery disease	5.86e-05	0.000325	CcSEcCtD
Etravirine—Diarrhoea—Trandolapril—coronary artery disease	5.85e-05	0.000324	CcSEcCtD
Etravirine—Vomiting—Valsartan—coronary artery disease	5.85e-05	0.000324	CcSEcCtD
Etravirine—Confusional state—Lisinopril—coronary artery disease	5.84e-05	0.000323	CcSEcCtD
Etravirine—Diarrhoea—Enalapril—coronary artery disease	5.83e-05	0.000323	CcSEcCtD
Etravirine—Dizziness—Pravastatin—coronary artery disease	5.83e-05	0.000323	CcSEcCtD
Etravirine—Vomiting—Olmesartan—coronary artery disease	5.82e-05	0.000323	CcSEcCtD
Etravirine—Rash—Valsartan—coronary artery disease	5.8e-05	0.000321	CcSEcCtD
Etravirine—Dermatitis—Valsartan—coronary artery disease	5.8e-05	0.000321	CcSEcCtD
Etravirine—Nausea—Simvastatin—coronary artery disease	5.79e-05	0.000321	CcSEcCtD
Etravirine—Rash—Olmesartan—coronary artery disease	5.78e-05	0.00032	CcSEcCtD
Etravirine—Insomnia—Ramipril—coronary artery disease	5.77e-05	0.00032	CcSEcCtD
Etravirine—Dermatitis—Olmesartan—coronary artery disease	5.77e-05	0.00032	CcSEcCtD
Etravirine—Headache—Valsartan—coronary artery disease	5.77e-05	0.000319	CcSEcCtD
Etravirine—Diarrhoea—Telmisartan—coronary artery disease	5.75e-05	0.000319	CcSEcCtD
Etravirine—Infection—Lisinopril—coronary artery disease	5.75e-05	0.000319	CcSEcCtD
Etravirine—Headache—Olmesartan—coronary artery disease	5.74e-05	0.000318	CcSEcCtD
Etravirine—Paraesthesia—Ramipril—coronary artery disease	5.73e-05	0.000318	CcSEcCtD
Etravirine—Shock—Lisinopril—coronary artery disease	5.7e-05	0.000315	CcSEcCtD
Etravirine—Asthenia—Perindopril—coronary artery disease	5.69e-05	0.000315	CcSEcCtD
Etravirine—Vomiting—Niacin—coronary artery disease	5.69e-05	0.000315	CcSEcCtD
Etravirine—Hypersensitivity—Furosemide—coronary artery disease	5.68e-05	0.000315	CcSEcCtD
Etravirine—Somnolence—Ramipril—coronary artery disease	5.67e-05	0.000314	CcSEcCtD
Etravirine—Thrombocytopenia—Lisinopril—coronary artery disease	5.67e-05	0.000314	CcSEcCtD
Etravirine—Dizziness—Trandolapril—coronary artery disease	5.66e-05	0.000313	CcSEcCtD
Etravirine—Insomnia—Timolol—coronary artery disease	5.64e-05	0.000313	CcSEcCtD
Etravirine—Rash—Niacin—coronary artery disease	5.64e-05	0.000313	CcSEcCtD
Etravirine—Dermatitis—Niacin—coronary artery disease	5.64e-05	0.000312	CcSEcCtD
Etravirine—Dizziness—Enalapril—coronary artery disease	5.64e-05	0.000312	CcSEcCtD
Etravirine—Skin disorder—Lisinopril—coronary artery disease	5.62e-05	0.000311	CcSEcCtD
Etravirine—Headache—Niacin—coronary artery disease	5.61e-05	0.000311	CcSEcCtD
Etravirine—Paraesthesia—Timolol—coronary artery disease	5.6e-05	0.00031	CcSEcCtD
Etravirine—Vomiting—Pravastatin—coronary artery disease	5.6e-05	0.00031	CcSEcCtD
Etravirine—Hyperhidrosis—Lisinopril—coronary artery disease	5.6e-05	0.00031	CcSEcCtD
Etravirine—Diarrhoea—Captopril—coronary artery disease	5.59e-05	0.00031	CcSEcCtD
Etravirine—Dizziness—Telmisartan—coronary artery disease	5.56e-05	0.000308	CcSEcCtD
Etravirine—Rash—Pravastatin—coronary artery disease	5.56e-05	0.000308	CcSEcCtD
Etravirine—Dermatitis—Pravastatin—coronary artery disease	5.55e-05	0.000307	CcSEcCtD
Etravirine—Decreased appetite—Ramipril—coronary artery disease	5.55e-05	0.000307	CcSEcCtD
Etravirine—Somnolence—Timolol—coronary artery disease	5.55e-05	0.000307	CcSEcCtD
Etravirine—Asthenia—Furosemide—coronary artery disease	5.54e-05	0.000307	CcSEcCtD
Etravirine—Headache—Pravastatin—coronary artery disease	5.52e-05	0.000306	CcSEcCtD
Etravirine—Anorexia—Lisinopril—coronary artery disease	5.52e-05	0.000306	CcSEcCtD
Etravirine—Gastrointestinal disorder—Ramipril—coronary artery disease	5.51e-05	0.000305	CcSEcCtD
Etravirine—Fatigue—Ramipril—coronary artery disease	5.5e-05	0.000305	CcSEcCtD
Etravirine—Hypersensitivity—Losartan—coronary artery disease	5.48e-05	0.000304	CcSEcCtD
Etravirine—Nausea—Valsartan—coronary artery disease	5.47e-05	0.000303	CcSEcCtD
Etravirine—Constipation—Ramipril—coronary artery disease	5.46e-05	0.000302	CcSEcCtD
Etravirine—Nausea—Olmesartan—coronary artery disease	5.44e-05	0.000301	CcSEcCtD
Etravirine—Vomiting—Trandolapril—coronary artery disease	5.44e-05	0.000301	CcSEcCtD
Etravirine—Diarrhoea—Perindopril—coronary artery disease	5.43e-05	0.000301	CcSEcCtD
Etravirine—Decreased appetite—Timolol—coronary artery disease	5.42e-05	0.0003	CcSEcCtD
Etravirine—Vomiting—Enalapril—coronary artery disease	5.42e-05	0.0003	CcSEcCtD
Etravirine—Dizziness—Captopril—coronary artery disease	5.41e-05	0.000299	CcSEcCtD
Etravirine—Rash—Trandolapril—coronary artery disease	5.4e-05	0.000299	CcSEcCtD
Etravirine—Dermatitis—Trandolapril—coronary artery disease	5.39e-05	0.000299	CcSEcCtD
Etravirine—Gastrointestinal disorder—Timolol—coronary artery disease	5.39e-05	0.000298	CcSEcCtD
Etravirine—Fatigue—Timolol—coronary artery disease	5.38e-05	0.000298	CcSEcCtD
Etravirine—Rash—Enalapril—coronary artery disease	5.37e-05	0.000298	CcSEcCtD
Etravirine—Dermatitis—Enalapril—coronary artery disease	5.37e-05	0.000297	CcSEcCtD
Etravirine—Headache—Trandolapril—coronary artery disease	5.36e-05	0.000297	CcSEcCtD
Etravirine—Vomiting—Telmisartan—coronary artery disease	5.34e-05	0.000296	CcSEcCtD
Etravirine—Asthenia—Losartan—coronary artery disease	5.34e-05	0.000296	CcSEcCtD
Etravirine—Headache—Enalapril—coronary artery disease	5.34e-05	0.000296	CcSEcCtD
Etravirine—Pain—Timolol—coronary artery disease	5.34e-05	0.000296	CcSEcCtD
Etravirine—Nausea—Niacin—coronary artery disease	5.32e-05	0.000294	CcSEcCtD
Etravirine—Rash—Telmisartan—coronary artery disease	5.3e-05	0.000294	CcSEcCtD
Etravirine—Dermatitis—Telmisartan—coronary artery disease	5.3e-05	0.000293	CcSEcCtD
Etravirine—Diarrhoea—Furosemide—coronary artery disease	5.28e-05	0.000292	CcSEcCtD
Etravirine—Headache—Telmisartan—coronary artery disease	5.27e-05	0.000292	CcSEcCtD
Etravirine—Feeling abnormal—Ramipril—coronary artery disease	5.26e-05	0.000291	CcSEcCtD
Etravirine—Dizziness—Perindopril—coronary artery disease	5.25e-05	0.000291	CcSEcCtD
Etravirine—Insomnia—Lisinopril—coronary artery disease	5.24e-05	0.00029	CcSEcCtD
Etravirine—Nausea—Pravastatin—coronary artery disease	5.23e-05	0.00029	CcSEcCtD
Etravirine—Gastrointestinal pain—Ramipril—coronary artery disease	5.22e-05	0.000289	CcSEcCtD
Etravirine—Paraesthesia—Lisinopril—coronary artery disease	5.2e-05	0.000288	CcSEcCtD
Etravirine—Vomiting—Captopril—coronary artery disease	5.2e-05	0.000288	CcSEcCtD
Etravirine—Rash—Captopril—coronary artery disease	5.15e-05	0.000286	CcSEcCtD
Etravirine—Dermatitis—Captopril—coronary artery disease	5.15e-05	0.000285	CcSEcCtD
Etravirine—Somnolence—Lisinopril—coronary artery disease	5.15e-05	0.000285	CcSEcCtD
Etravirine—Feeling abnormal—Timolol—coronary artery disease	5.14e-05	0.000285	CcSEcCtD
Etravirine—Headache—Captopril—coronary artery disease	5.12e-05	0.000284	CcSEcCtD
Etravirine—Gastrointestinal pain—Timolol—coronary artery disease	5.1e-05	0.000283	CcSEcCtD
Etravirine—Dizziness—Furosemide—coronary artery disease	5.1e-05	0.000283	CcSEcCtD
Etravirine—Diarrhoea—Losartan—coronary artery disease	5.09e-05	0.000282	CcSEcCtD
Etravirine—Nausea—Trandolapril—coronary artery disease	5.08e-05	0.000282	CcSEcCtD
Etravirine—Nausea—Enalapril—coronary artery disease	5.06e-05	0.00028	CcSEcCtD
Etravirine—Vomiting—Perindopril—coronary artery disease	5.05e-05	0.00028	CcSEcCtD
Etravirine—Abdominal pain—Ramipril—coronary artery disease	5.05e-05	0.00028	CcSEcCtD
Etravirine—Body temperature increased—Ramipril—coronary artery disease	5.05e-05	0.00028	CcSEcCtD
Etravirine—Decreased appetite—Lisinopril—coronary artery disease	5.03e-05	0.000279	CcSEcCtD
Etravirine—Rash—Perindopril—coronary artery disease	5e-05	0.000277	CcSEcCtD
Etravirine—Dermatitis—Perindopril—coronary artery disease	5e-05	0.000277	CcSEcCtD
Etravirine—Gastrointestinal disorder—Lisinopril—coronary artery disease	5e-05	0.000277	CcSEcCtD
Etravirine—Nausea—Telmisartan—coronary artery disease	4.99e-05	0.000277	CcSEcCtD
Etravirine—Fatigue—Lisinopril—coronary artery disease	4.99e-05	0.000276	CcSEcCtD
Etravirine—Headache—Perindopril—coronary artery disease	4.97e-05	0.000275	CcSEcCtD
Etravirine—Pain—Lisinopril—coronary artery disease	4.95e-05	0.000274	CcSEcCtD
Etravirine—Constipation—Lisinopril—coronary artery disease	4.95e-05	0.000274	CcSEcCtD
Etravirine—Abdominal pain—Timolol—coronary artery disease	4.93e-05	0.000273	CcSEcCtD
Etravirine—Body temperature increased—Timolol—coronary artery disease	4.93e-05	0.000273	CcSEcCtD
Etravirine—Dizziness—Losartan—coronary artery disease	4.92e-05	0.000273	CcSEcCtD
Etravirine—Vomiting—Furosemide—coronary artery disease	4.91e-05	0.000272	CcSEcCtD
Etravirine—Rash—Furosemide—coronary artery disease	4.86e-05	0.000269	CcSEcCtD
Etravirine—Dermatitis—Furosemide—coronary artery disease	4.86e-05	0.000269	CcSEcCtD
Etravirine—Nausea—Captopril—coronary artery disease	4.86e-05	0.000269	CcSEcCtD
Etravirine—Headache—Furosemide—coronary artery disease	4.83e-05	0.000268	CcSEcCtD
Etravirine—Feeling abnormal—Lisinopril—coronary artery disease	4.77e-05	0.000264	CcSEcCtD
Etravirine—Gastrointestinal pain—Lisinopril—coronary artery disease	4.73e-05	0.000262	CcSEcCtD
Etravirine—Vomiting—Losartan—coronary artery disease	4.73e-05	0.000262	CcSEcCtD
Etravirine—Nausea—Perindopril—coronary artery disease	4.71e-05	0.000261	CcSEcCtD
Etravirine—Hypersensitivity—Ramipril—coronary artery disease	4.7e-05	0.000261	CcSEcCtD
Etravirine—Rash—Losartan—coronary artery disease	4.69e-05	0.00026	CcSEcCtD
Etravirine—Dermatitis—Losartan—coronary artery disease	4.69e-05	0.00026	CcSEcCtD
Etravirine—Headache—Losartan—coronary artery disease	4.66e-05	0.000258	CcSEcCtD
Etravirine—Hypersensitivity—Timolol—coronary artery disease	4.6e-05	0.000255	CcSEcCtD
Etravirine—Nausea—Furosemide—coronary artery disease	4.58e-05	0.000254	CcSEcCtD
Etravirine—Asthenia—Ramipril—coronary artery disease	4.58e-05	0.000254	CcSEcCtD
Etravirine—Body temperature increased—Lisinopril—coronary artery disease	4.58e-05	0.000253	CcSEcCtD
Etravirine—Abdominal pain—Lisinopril—coronary artery disease	4.58e-05	0.000253	CcSEcCtD
Etravirine—Asthenia—Timolol—coronary artery disease	4.48e-05	0.000248	CcSEcCtD
Etravirine—Nausea—Losartan—coronary artery disease	4.42e-05	0.000245	CcSEcCtD
Etravirine—Diarrhoea—Ramipril—coronary artery disease	4.37e-05	0.000242	CcSEcCtD
Etravirine—Diarrhoea—Timolol—coronary artery disease	4.27e-05	0.000237	CcSEcCtD
Etravirine—Hypersensitivity—Lisinopril—coronary artery disease	4.26e-05	0.000236	CcSEcCtD
Etravirine—Dizziness—Ramipril—coronary artery disease	4.22e-05	0.000234	CcSEcCtD
Etravirine—Asthenia—Lisinopril—coronary artery disease	4.15e-05	0.00023	CcSEcCtD
Etravirine—Dizziness—Timolol—coronary artery disease	4.13e-05	0.000229	CcSEcCtD
Etravirine—Vomiting—Ramipril—coronary artery disease	4.06e-05	0.000225	CcSEcCtD
Etravirine—Rash—Ramipril—coronary artery disease	4.02e-05	0.000223	CcSEcCtD
Etravirine—Dermatitis—Ramipril—coronary artery disease	4.02e-05	0.000223	CcSEcCtD
Etravirine—Headache—Ramipril—coronary artery disease	4e-05	0.000222	CcSEcCtD
Etravirine—Vomiting—Timolol—coronary artery disease	3.97e-05	0.00022	CcSEcCtD
Etravirine—Diarrhoea—Lisinopril—coronary artery disease	3.96e-05	0.000219	CcSEcCtD
Etravirine—Rash—Timolol—coronary artery disease	3.93e-05	0.000218	CcSEcCtD
Etravirine—Dermatitis—Timolol—coronary artery disease	3.93e-05	0.000218	CcSEcCtD
Etravirine—Headache—Timolol—coronary artery disease	3.91e-05	0.000217	CcSEcCtD
Etravirine—Dizziness—Lisinopril—coronary artery disease	3.83e-05	0.000212	CcSEcCtD
Etravirine—Nausea—Ramipril—coronary artery disease	3.79e-05	0.00021	CcSEcCtD
Etravirine—Nausea—Timolol—coronary artery disease	3.71e-05	0.000205	CcSEcCtD
Etravirine—Vomiting—Lisinopril—coronary artery disease	3.68e-05	0.000204	CcSEcCtD
Etravirine—Rash—Lisinopril—coronary artery disease	3.65e-05	0.000202	CcSEcCtD
Etravirine—Dermatitis—Lisinopril—coronary artery disease	3.65e-05	0.000202	CcSEcCtD
Etravirine—Headache—Lisinopril—coronary artery disease	3.63e-05	0.000201	CcSEcCtD
Etravirine—Nausea—Lisinopril—coronary artery disease	3.44e-05	0.00019	CcSEcCtD
Etravirine—CYP2C9—Metabolism—HK1—coronary artery disease	7.87e-06	0.000132	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ABCG5—coronary artery disease	7.87e-06	0.000132	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SULT1A1—coronary artery disease	7.87e-06	0.000132	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	7.86e-06	0.000132	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—P4HB—coronary artery disease	7.84e-06	0.000132	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—APOA5—coronary artery disease	7.8e-06	0.000131	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PYGB—coronary artery disease	7.78e-06	0.000131	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CKB—coronary artery disease	7.78e-06	0.000131	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—HADHA—coronary artery disease	7.78e-06	0.000131	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	7.76e-06	0.000131	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PLA2G1B—coronary artery disease	7.69e-06	0.000129	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTA1—coronary artery disease	7.69e-06	0.000129	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—P4HB—coronary artery disease	7.65e-06	0.000129	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	7.61e-06	0.000128	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—LPA—coronary artery disease	7.6e-06	0.000128	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	7.52e-06	0.000126	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PLA2G1B—coronary artery disease	7.51e-06	0.000126	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	7.5e-06	0.000126	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PLCB3—coronary artery disease	7.36e-06	0.000124	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—DLAT—coronary artery disease	7.32e-06	0.000123	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PLIN1—coronary artery disease	7.32e-06	0.000123	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTM2—coronary artery disease	7.32e-06	0.000123	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—COX5B—coronary artery disease	7.32e-06	0.000123	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PFKFB3—coronary artery disease	7.32e-06	0.000123	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—APOA5—coronary artery disease	7.29e-06	0.000123	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—VCAN—coronary artery disease	7.25e-06	0.000122	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALDOA—coronary artery disease	7.2e-06	0.000121	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—P4HB—coronary artery disease	7.15e-06	0.00012	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	7.08e-06	0.000119	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—VCAN—coronary artery disease	7.08e-06	0.000119	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALDOA—coronary artery disease	7.02e-06	0.000118	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PLA2G1B—coronary artery disease	7.02e-06	0.000118	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—DCN—coronary artery disease	6.99e-06	0.000117	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—APOA1—coronary artery disease	6.98e-06	0.000117	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	6.94e-06	0.000117	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SULT1E1—coronary artery disease	6.93e-06	0.000117	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	6.86e-06	0.000115	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—DCN—coronary artery disease	6.82e-06	0.000115	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALDH2—coronary artery disease	6.8e-06	0.000114	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALDH2—coronary artery disease	6.63e-06	0.000112	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	6.63e-06	0.000111	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—HBA1—coronary artery disease	6.62e-06	0.000111	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—LIPC—coronary artery disease	6.62e-06	0.000111	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3C2A—coronary artery disease	6.62e-06	0.000111	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HK2—coronary artery disease	6.62e-06	0.000111	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—AKR1B1—coronary artery disease	6.62e-06	0.000111	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—VCAN—coronary artery disease	6.61e-06	0.000111	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—APOC3—coronary artery disease	6.58e-06	0.000111	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALDOA—coronary artery disease	6.56e-06	0.00011	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—LDLR—coronary artery disease	6.54e-06	0.00011	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	6.54e-06	0.00011	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—HBA1—coronary artery disease	6.46e-06	0.000109	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—LIPC—coronary artery disease	6.46e-06	0.000109	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SLC9A1—coronary artery disease	6.46e-06	0.000109	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTT1—coronary artery disease	6.46e-06	0.000109	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP2C19—coronary artery disease	6.46e-06	0.000109	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3C2A—coronary artery disease	6.46e-06	0.000109	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—APOC3—coronary artery disease	6.42e-06	0.000108	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GCLC—coronary artery disease	6.39e-06	0.000107	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CETP—coronary artery disease	6.39e-06	0.000107	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—LDLR—coronary artery disease	6.39e-06	0.000107	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—DCN—coronary artery disease	6.37e-06	0.000107	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SLC27A1—coronary artery disease	6.34e-06	0.000107	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SDC1—coronary artery disease	6.32e-06	0.000106	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SLC9A1—coronary artery disease	6.31e-06	0.000106	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTT1—coronary artery disease	6.31e-06	0.000106	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CETP—coronary artery disease	6.24e-06	0.000105	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GCLC—coronary artery disease	6.24e-06	0.000105	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CPT1B—coronary artery disease	6.22e-06	0.000105	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—LCAT—coronary artery disease	6.22e-06	0.000105	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALDH2—coronary artery disease	6.2e-06	0.000104	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SDC1—coronary artery disease	6.17e-06	0.000104	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	6.12e-06	0.000103	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—APOA4—coronary artery disease	6.11e-06	0.000103	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	6.04e-06	0.000102	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—HBA1—coronary artery disease	6.04e-06	0.000102	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—LIPC—coronary artery disease	6.04e-06	0.000102	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	6.04e-06	0.000102	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP2C19—coronary artery disease	6.04e-06	0.000102	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—APOC3—coronary artery disease	6e-06	0.000101	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PSMA6—coronary artery disease	5.97e-06	0.0001	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PSMB5—coronary artery disease	5.97e-06	0.0001	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—LDLR—coronary artery disease	5.97e-06	0.0001	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	5.96e-06	0.0001	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	5.96e-06	0.0001	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PDHA1—coronary artery disease	5.9e-06	9.91e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GCLM—coronary artery disease	5.9e-06	9.91e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTT1—coronary artery disease	5.89e-06	9.91e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SLC9A1—coronary artery disease	5.89e-06	9.91e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CTGF—coronary artery disease	5.83e-06	9.8e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GCLC—coronary artery disease	5.83e-06	9.8e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CETP—coronary artery disease	5.83e-06	9.8e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PSMA6—coronary artery disease	5.83e-06	9.8e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PSMB5—coronary artery disease	5.83e-06	9.8e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—HMGCR—coronary artery disease	5.78e-06	9.72e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GOT2—coronary artery disease	5.78e-06	9.72e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SDC1—coronary artery disease	5.76e-06	9.69e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—TXNRD1—coronary artery disease	5.71e-06	9.6e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP11B2—coronary artery disease	5.71e-06	9.6e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CTGF—coronary artery disease	5.69e-06	9.57e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—HMGCR—coronary artery disease	5.64e-06	9.48e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GOT2—coronary artery disease	5.64e-06	9.48e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SLC22A3—coronary artery disease	5.62e-06	9.46e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HADH—coronary artery disease	5.54e-06	9.32e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ARNTL—coronary artery disease	5.54e-06	9.32e-05	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	5.53e-06	9.3e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PSMA6—coronary artery disease	5.44e-06	9.15e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PSMB5—coronary artery disease	5.44e-06	9.15e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	5.43e-06	9.13e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CTGF—coronary artery disease	5.32e-06	8.94e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PLCB1—coronary artery disease	5.31e-06	8.93e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—HMGCR—coronary artery disease	5.27e-06	8.86e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GOT2—coronary artery disease	5.27e-06	8.86e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GPX2—coronary artery disease	5.26e-06	8.84e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	5.26e-06	8.84e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—APOA2—coronary artery disease	5.26e-06	8.84e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	5.21e-06	8.76e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ABCG5—coronary artery disease	5.19e-06	8.73e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GPX4—coronary artery disease	5.19e-06	8.73e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SULT1A1—coronary artery disease	5.19e-06	8.73e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HK1—coronary artery disease	5.19e-06	8.73e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PLCB1—coronary artery disease	5.19e-06	8.72e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ABCA1—coronary artery disease	5.15e-06	8.66e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HADHA—coronary artery disease	5.13e-06	8.62e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTA1—coronary artery disease	5.07e-06	8.52e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ABCA1—coronary artery disease	5.03e-06	8.45e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—LPA—coronary artery disease	5.01e-06	8.43e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GOT1—coronary artery disease	4.99e-06	8.39e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GGT1—coronary artery disease	4.99e-06	8.39e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GGT1—coronary artery disease	4.87e-06	8.19e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GOT1—coronary artery disease	4.87e-06	8.19e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PLCB3—coronary artery disease	4.86e-06	8.16e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PLCB1—coronary artery disease	4.85e-06	8.15e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—APOA5—coronary artery disease	4.81e-06	8.08e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	4.75e-06	7.99e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—P4HB—coronary artery disease	4.71e-06	7.93e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ABCA1—coronary artery disease	4.7e-06	7.9e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	4.63e-06	7.78e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GGT1—coronary artery disease	4.55e-06	7.65e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GOT1—coronary artery disease	4.55e-06	7.65e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTP1—coronary artery disease	4.48e-06	7.53e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	4.44e-06	7.46e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—HMOX1—coronary artery disease	4.42e-06	7.43e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTP1—coronary artery disease	4.37e-06	7.35e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—VCAN—coronary artery disease	4.36e-06	7.33e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CAT—coronary artery disease	4.36e-06	7.33e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PPARGC1A—coronary artery disease	4.33e-06	7.29e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALDOA—coronary artery disease	4.33e-06	7.28e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—HMOX1—coronary artery disease	4.31e-06	7.25e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CAT—coronary artery disease	4.26e-06	7.16e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—APOB—coronary artery disease	4.23e-06	7.12e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—DCN—coronary artery disease	4.2e-06	7.06e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—APOB—coronary artery disease	4.13e-06	6.95e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTM1—coronary artery disease	4.12e-06	6.92e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALDH2—coronary artery disease	4.09e-06	6.87e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTP1—coronary artery disease	4.09e-06	6.87e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	4.05e-06	6.81e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—LPL—coronary artery disease	4.04e-06	6.8e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—HMOX1—coronary artery disease	4.03e-06	6.77e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTM1—coronary artery disease	4.02e-06	6.76e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—LIPC—coronary artery disease	3.98e-06	6.7e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HBA1—coronary artery disease	3.98e-06	6.7e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	3.98e-06	6.7e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP2C19—coronary artery disease	3.98e-06	6.7e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CAT—coronary artery disease	3.98e-06	6.68e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—APOC3—coronary artery disease	3.96e-06	6.65e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—LPL—coronary artery disease	3.94e-06	6.63e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GPX1—coronary artery disease	3.94e-06	6.63e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—LDLR—coronary artery disease	3.93e-06	6.61e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SLC9A1—coronary artery disease	3.89e-06	6.54e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTT1—coronary artery disease	3.89e-06	6.54e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—APOB—coronary artery disease	3.86e-06	6.49e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GPX1—coronary artery disease	3.85e-06	6.47e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CETP—coronary artery disease	3.84e-06	6.46e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GCLC—coronary artery disease	3.84e-06	6.46e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CD36—coronary artery disease	3.84e-06	6.46e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SDC1—coronary artery disease	3.8e-06	6.39e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PPP2CA—coronary artery disease	3.79e-06	6.38e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTM1—coronary artery disease	3.75e-06	6.31e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CD36—coronary artery disease	3.75e-06	6.3e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PPP2CA—coronary artery disease	3.7e-06	6.22e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—LPL—coronary artery disease	3.69e-06	6.2e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—MTHFR—coronary artery disease	3.64e-06	6.12e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GPX1—coronary artery disease	3.6e-06	6.05e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PSMB5—coronary artery disease	3.59e-06	6.04e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PSMA6—coronary artery disease	3.59e-06	6.04e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—MTHFR—coronary artery disease	3.55e-06	5.97e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CTGF—coronary artery disease	3.51e-06	5.9e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CD36—coronary artery disease	3.5e-06	5.89e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GOT2—coronary artery disease	3.48e-06	5.84e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HMGCR—coronary artery disease	3.48e-06	5.84e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PPP2CA—coronary artery disease	3.46e-06	5.81e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—AGT—coronary artery disease	3.46e-06	5.81e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—APOE—coronary artery disease	3.39e-06	5.7e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—AGT—coronary artery disease	3.37e-06	5.67e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—APOA1—coronary artery disease	3.35e-06	5.63e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—MTHFR—coronary artery disease	3.32e-06	5.58e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—APOE—coronary artery disease	3.31e-06	5.56e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—APOA1—coronary artery disease	3.27e-06	5.5e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.21e-06	5.39e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PLCB1—coronary artery disease	3.2e-06	5.37e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—AGT—coronary artery disease	3.15e-06	5.3e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ABCA1—coronary artery disease	3.1e-06	5.21e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—APOE—coronary artery disease	3.09e-06	5.19e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—APOA1—coronary artery disease	3.05e-06	5.13e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GGT1—coronary artery disease	3e-06	5.04e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GOT1—coronary artery disease	3e-06	5.04e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PPARG—coronary artery disease	2.95e-06	4.96e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.92e-06	4.92e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—POMC—coronary artery disease	2.91e-06	4.89e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PPARG—coronary artery disease	2.88e-06	4.84e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—POMC—coronary artery disease	2.84e-06	4.78e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.69e-06	4.53e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PPARG—coronary artery disease	2.69e-06	4.52e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.67e-06	4.49e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.66e-06	4.47e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—POMC—coronary artery disease	2.65e-06	4.46e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALB—coronary artery disease	2.65e-06	4.46e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CAT—coronary artery disease	2.62e-06	4.41e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALB—coronary artery disease	2.59e-06	4.35e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—APOB—coronary artery disease	2.55e-06	4.28e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NOS3—coronary artery disease	2.54e-06	4.27e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NOS3—coronary artery disease	2.48e-06	4.17e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTM1—coronary artery disease	2.48e-06	4.16e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—LPL—coronary artery disease	2.43e-06	4.09e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALB—coronary artery disease	2.42e-06	4.07e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GPX1—coronary artery disease	2.37e-06	3.99e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PTGS2—coronary artery disease	2.32e-06	3.9e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NOS3—coronary artery disease	2.31e-06	3.89e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CD36—coronary artery disease	2.31e-06	3.88e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	2.28e-06	3.83e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PTGS2—coronary artery disease	2.27e-06	3.81e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—MTHFR—coronary artery disease	2.19e-06	3.68e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PTGS2—coronary artery disease	2.12e-06	3.56e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—AGT—coronary artery disease	2.08e-06	3.5e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—APOE—coronary artery disease	2.04e-06	3.43e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—APOA1—coronary artery disease	2.01e-06	3.39e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PPARG—coronary artery disease	1.77e-06	2.98e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—POMC—coronary artery disease	1.75e-06	2.94e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALB—coronary artery disease	1.6e-06	2.68e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NOS3—coronary artery disease	1.53e-06	2.57e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CA—coronary artery disease	1.43e-06	2.4e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.4e-06	2.35e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CA—coronary artery disease	1.39e-06	2.34e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CA—coronary artery disease	1.3e-06	2.19e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—AKT1—coronary artery disease	1.17e-06	1.96e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—AKT1—coronary artery disease	1.14e-06	1.91e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—AKT1—coronary artery disease	1.06e-06	1.79e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	8.59e-07	1.44e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—AKT1—coronary artery disease	7.02e-07	1.18e-05	CbGpPWpGaD
